---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-002326"
form_type: "8-K"
ticker: "ZEOX"
cik: "0001557376"
company_name: "Zeo ScientifiX, Inc."
filed_at: "2025-04-02T23:59:59+00:00"
generated_at: "2026-05-23T23:40:03.587237+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Appoints Ron Borsheim as Chief Sales Officer - Aesthetics effective April 1, 2025

## Summary
- Base salary of $225,000 per year; option to purchase 40,000 shares at $2.50/share.
- Option vests 50% on first anniversary, 50% on second anniversary; five-year term.
- Borsheim has 30+ years experience in aesthetic and regenerative medicine sales, previously at Benev Company, Sofwave Medical, BTL Industries.
- Severance: 1/4 month salary per 3 months completed after 90 days if terminated without cause or for good reason.
- Position reports to CEO; remote work from Jacksonville Beach, FL with travel to headquarters.

## SEC filing metadata
- accession: 0001829126-25-002326
- form_type: 8-K
- ticker: ZEOX
- cik: 0001557376
- company_name: Zeo ScientifiX, Inc.
- filed_at: 2025-04-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1557376/000182912625002326/0001829126-25-002326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1557376/000182912625002326/zeoscientifix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-002326
- JSON: https://secwatch.observer/filing/0001829126-25-002326.json
- Plain text: https://secwatch.observer/filing/0001829126-25-002326.txt

## Key facts
- Executive change
  Ron Borsheim was appointed as Chief Sales Officer - Aesthetics at Zeo ScientifiX, Inc..
  - Action: appointed
  - Role: Chief Sales Officer - Aesthetics
  source text: Effective April 1, 2025, Ron Borsheim was appointed the Company’s Chief Sales Officer - Aesthetics.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1557376/000182912625002326/0001829126-25-002326-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.